Literature DB >> 25142429

DYT16 revisited: exome sequencing identifies PRKRA mutations in a European dystonia family.

Michael Zech1, Florian Castrop, Barbara Schormair, Angela Jochim, Thomas Wieland, Nadine Gross, Peter Lichtner, Annette Peters, Christian Gieger, Thomas Meitinger, Tim M Strom, Konrad Oexle, Bernhard Haslinger, Juliane Winkelmann.   

Abstract

Recessive DYT16 dystonia associated with mutations in PRKRA has until now been reported only in seven Brazilian patients. The aim of this study was to elucidate the genetic cause underlying disease in a Polish family with autosomal-recessive, early-onset generalized dystonia and slight parkinsonism, and to explore further the role of PRKRA in a dystonia series of European ancestry. We employed whole-exome sequencing in two affected siblings of the Polish family and filtered for rare homozygous and compound heterozygous variants shared by both exomes. Validation of the identified variants as well as homozygosity screening and copy number variation analysis was carried out in the two affected individuals and their healthy siblings. PRKRA was analyzed in 339 German patients with various forms of dystonia and 376 population-based controls by direct sequencing or high-resolution melting. The previously described homozygous p.Pro222Leu mutation in PRKRA was found to segregate with the disease in the studied family, contained in a 1.2 Mb homozygous region identical by state with all Brazilian patients in chromosome 2q31.2. The clinical presentation with young-onset, progressive generalized dystonia and mild parkinsonism resembled the phenotype of the original DYT16 cases. PRKRA mutational screening in additional dystonia samples revealed three novel heterozygous changes (p.Thr34Ser, p.Asn102Ser, c.-14A>G), each in a single subject with focal/segmental dystonia. Our study provides the first independent replication of the DYT16 locus at 2q31.2 and strongly confirms the causal contribution of the PRKRA gene to DYT16. Our data suggest worldwide involvement of PRKRA in dystonia.
© 2014 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  DYT16; PRKRA; dystonia; gene

Mesh:

Substances:

Year:  2014        PMID: 25142429     DOI: 10.1002/mds.25981

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  13 in total

1.  Imaging Evidence of Nigrostriatal Degeneration in DYT-PRKRA.

Authors:  Maria João Pinto; Ana Oliveira; Maria José Rosas; João Massano
Journal:  Mov Disord Clin Pract       Date:  2020-04-06

2.  The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants.

Authors:  Marc A Mergy; Raajaram Gowrishankar; Paul J Gresch; Stephanie C Gantz; John Williams; Gwynne L Davis; C Austin Wheeler; Gregg D Stanwood; Maureen K Hahn; Randy D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

3.  Novel compound heterozygous mutations in PRKRA cause pure dystonia.

Authors:  Patricia de Carvalho Aguiar; Vanderci Borges; Henrique Ballalai Ferraz; Laurie Jean Ozelius
Journal:  Mov Disord       Date:  2015-03-04       Impact factor: 10.338

4.  A truncated PACT protein resulting from a frameshift mutation reported in movement disorder DYT16 triggers caspase activation and apoptosis.

Authors:  Samuel B Burnett; Lauren S Vaughn; Joelle M Strom; Ashley Francois; Rekha C Patel
Journal:  J Cell Biochem       Date:  2019-06-27       Impact factor: 4.429

5.  PRKRAP1 Pseudogene Complicating the Diagnosis of Young-Onset Dystonia Due to PRKRA Gene Disease-Causing Variants (DYT-PRKRA).

Authors:  Joana Afonso Ribeiro; Mário Sousa; Isabel Alonso; Fradique Moreira; Ricardo Pereira; Filipe Palavra
Journal:  Mov Disord Clin Pract       Date:  2022-03-04

Review 6.  The apparent paradox of phenotypic diversity and shared mechanisms across dystonia syndromes.

Authors:  Alessio Di Fonzo; Alberto Albanese; Hyder A Jinnah
Journal:  Curr Opin Neurol       Date:  2022-07-05       Impact factor: 6.283

7.  DYT-PRKRA Mutation P222L Enhances PACT's Stimulatory Activity on Type I Interferon Induction.

Authors:  Lauren S Vaughn; Kenneth Frederick; Samuel B Burnett; Nutan Sharma; D Cristopher Bragg; Sarah Camargos; Francisco Cardoso; Rekha C Patel
Journal:  Biomolecules       Date:  2022-05-17

8.  Discovery and characterization of spontaneous mouse models of craniofacial dysmorphology.

Authors:  Kristina Palmer; Heather Fairfield; Suhaib Borgeia; Michelle Curtain; Mohamed G Hassan; Louise Dionne; Son Yong Karst; Harold Coombs; Roderick T Bronson; Laura G Reinholdt; David E Bergstrom; Leah Rae Donahue; Timothy C Cox; Stephen A Murray
Journal:  Dev Biol       Date:  2015-07-31       Impact factor: 3.582

9.  Altered activation of protein kinase PKR and enhanced apoptosis in dystonia cells carrying a mutation in PKR activator protein PACT.

Authors:  Lauren S Vaughn; D Cristopher Bragg; Nutan Sharma; Sarah Camargos; Francisco Cardoso; Rekha C Patel
Journal:  J Biol Chem       Date:  2015-07-31       Impact factor: 5.157

Review 10.  Combined dystonias: clinical and genetic updates.

Authors:  Anne Weissbach; Gerard Saranza; Aloysius Domingo
Journal:  J Neural Transm (Vienna)       Date:  2020-10-24       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.